Bausch & Lomb's major customers
Cardinal Health accounted for 10% of Bausch & Lomb's revenue in FY 2025, about the same as 10% a year earlier.
Get an email when Bausch & Lomb's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of Bausch & Lomb
Customers that Bausch & Lomb named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Cardinal HealthCAH | 10% | from 10% | 2 years | FY 2025 · filed 18 Feb 2026 |
| McKessonMCK | 10% | from 10% | 2 years | FY 2025 · filed 18 Feb 2026 |
Suppliers that depend on Bausch & Lomb
Listed companies whose annual report names Bausch & Lomb as a customer worth 10% or more of their revenue. If Bausch & Lomb cuts orders or switches supplier, these are the companies that feel it.
Formerly disclosed
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| EyePointEYPT | 35% | last FY 2018 | 6 years | FY 2018 · filed 18 Sept 2018 |
| Anika TherapeuticsANIK | 3% | last FY 2014 | 4 years | FY 2014 · filed 13 Mar 2015 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API